Related Experiment Video
Updated: Jan 27, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Benefits of hepatitis C cure with antivirals: why test and treat?
Gema Lledó1, Laura Benítez-Gutiérrez1, Ana Arias1
1Internal Medicine Department, Hospital Puerta de Hierro-Majadahonda, Madrid, Spain.
Insights
Direct-acting antivirals offer a high cure rate for chronic hepatitis C virus (HCV) infection, leading to liver improvements and reduced cancer risk. Eradicating HCV also yields significant extrahepatic benefits, including better brain function and heart health.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Chronic hepatitis C virus (HCV) infection remains a significant global health concern.
- Direct-acting antivirals (DAAs) represent a breakthrough in HCV treatment.
- DAAs offer high cure rates, even in patients with advanced liver disease.
Purpose of the Study:
- To review the efficacy and benefits of direct-acting antivirals for HCV.
- To highlight the impact of HCV eradication on both hepatic and extrahepatic conditions.
- To discuss the role of DAAs in global HCV transmission control.
Main Methods:
- Literature review of studies on direct-acting antiviral therapy for HCV.
- Analysis of clinical outcomes, including viral eradication, liver fibrosis, and hepatocellular carcinoma risk.
- Evaluation of extrahepatic manifestations and public health implications.
Main Results:
- DAAs achieve high sustained virologic response rates, leading to HCV elimination.
- HCV cure is associated with regression of liver fibrosis and reduced risk of hepatocellular carcinoma.
- Sustained HCV eradication demonstrates extrahepatic benefits, such as improved neurocognitive function and cardiovascular health.
Conclusions:
- Direct-acting antivirals are highly effective for curing chronic HCV infection.
- HCV eradication provides significant hepatic and extrahepatic advantages.
- DAAs are crucial in reducing global HCV transmission in the absence of a vaccine.
Abstract:
Chronic hepatitis C virus (HCV) infection is one of the major causes of death worldwide due to infectious agents. The advent of direct-acting antivirals has dramatically improved the chance of HCV elimination, even for patients with decompensated cirrhosis. Along with HCV cure, benefits are recognized in terms of regression of liver fibrosis and risk of hepatocellular carcinoma. Furthermore, beyond hepatic outcomes, several extrahepatic benefits may result from sustained HCV eradication, including improvements in the neurocognitive function and reduced cardiovascular disease risk. Finally, there is no doubt that the individual success of direct-acting antivirals is largely contributing to halt HCV transmission globally, in the absence of an effective HCV prophylactic vaccine.
Related Concept Videos
Curing of Concrete
Curing Methods
Accelerated Curing of Concrete
Benefits of Self-Esteem
The Antiviral System of Bacteria and Archaea: CRISPR
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

